Differences in Efficacy and Cytokine Profiles following Echinocandin or Liposomal Amphotericin B Monotherapy or Combination Therapy for Murine Pulmonary or Systemic Aspergillus flavus Infections

Given the recent increase in aspergillosis caused by species other than Aspergillus fumigatus, micafungin, caspofungin, and liposomal amphotericin B (L-AmBi) were investigated as monotherapy or combination therapy for murine systemic or pulmonary Aspergillus flavus infection. Treatment for 3 or 6 da...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Olson, J. A., Schwartz, J., Hahka, D., George, A., Proffitt, R. T., Adler-Moore, J. P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3256087/
https://ncbi.nlm.nih.gov/pubmed/21968353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00607-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados